Table 1 |
|
|
Baseline Characteristics |
|
| Baseline Characteristics |
|
|
|
|
| JIA category |
|
| Systemic Arthritis |
7 (7%) |
| Oligoarthritis |
21 (21%) |
| Polyarthritis RF+ |
6 (6%) |
| Polyarthritis RF- |
17 (17%) |
| Psoriatic |
7 (7%) |
| ERA |
30(30%) |
| Undifferentiated |
12 (12%) |
|
|
|
| Age at diagnosis (mean in years +/- 1 std dev) |
9.84 +/- 4.81 |
|
|
|
| Female |
68% |
|
|
|
| AJC = 0 |
63 (63%) |
| AJC > = 1 |
37 (37%) |
|
|
|
| DMARD use (ever) |
49.4% |
|
|
|
| Education on track * |
90% |
|
|
|
|
*9 missing values DMARD- Disease modifying Agent of Rheumatic Disease AJC- Active Joint Count n- number %- per cent Std dev- standard deviation |
|
|
Hazel et al. Pediatric Rheumatology 2010 8:2 doi:10.1186/1546-0096-8-2 |
|
